The selected traditional chinese medicinal formulas for treating diabetic nephropathy: Perspective of modern science

Journal of Traditional and Complementary Medicine

Volumn 3, Issue 3, 2013, Pages 152-158

  Tzeng, Thing Fong ^a   Liou, Shorong Shii ^a   Liu, I Min ^a  

^a TAJEN UNIVERSITY   (Taiwan)

Author keywords

Danggui Buxue Tang; Danggui Shaoyao San; Diabetic nephropathy; Traditional Chinese medicine; Wu Ling San

Indexed keywords

EID: 84894527933     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.4103/2225-4110.114893     Document Type: Article

References (60)

1. Vivian EM. Type 2 diabetes in children and adolescents-the next epidemic? Curr Med Res Opin 2006;22:297-306.
2. Arredondo A. Diabetes: A global challenge with high economic burden for public health systems and society. Am J Public Health 2013;103:e1-2.
3. Rossing P. Diabetic nephropathy: Worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 2006;6:479-83.
4. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, et al. Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008;233:4-11.
5. LeRoith D, Rayfield EJ. The benefits of tight glycemic control in type 2 diabetes mellitus. Clin Cornerstone 2007;8 Suppl 7:S19-29.
6. Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev 2010;3:101-8.
7. Glandt M, Bloomgarden ZT. Hypertension in diabetes: Treatment considerations. J Clin Hypertens (Greenwich) 2011;13:314-8.
8. Kolasinska-Malkowska K, Filipiak KJ, Gwizdala A, Tykarski A. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications. Expert Rev Cardiovasc Ther 2008;6:759-71.
9. Schrijvers BF, De Vriese AS. Novel insights in the treatment of diabetic nephropathy. Acta Clin Belg 2007;62:278-90.
10. Cheng JT. Review: Drug therapy in Chinese traditional medicine. J Clin Pharmacol 2000;40:445-50.
11. Poon TY, Ong KL, Cheung BM. Review of the effects of the traditional Chinese medicine Rehmannia six formula on diabetes mellitus and its complications. J Diabetes 2011;3:184-200.
12. Guangdong Medical Journal Editorial Department. Clinical observation of curative effects of Wu Ling San for treatment of glaucoma. Guangdong Yi Xue 1982;3:40.
13. Chen DA. Treating 27 cases of edema in the lower limbs with Wu Ling San. Xinjiang Zhong Yi Yao 1998;16:19-20.
14. Liu QL, Sato S, Kishikawa T, Matsuzaki H, Yamanaka N. Effectiveness of a traditional Chinese medicine, Wulingsan, in suppressing the development of nephrocalcinosis induced by a high phosphorus diet in young rats. Med Electron Microsc 2001;34:103-14.
15. Hattori T, Fujitsuka N, Kurogi A, Shindo S. Sairei-to may inhibit the synthesis of endothelin-1 in nephritic glomeruli. Nippon Jinzo Gakkai Shi 1997;39:121-8.
16. Yoshimura K, Miyake O, Okuyama A, Yoshioka T, Honda M, Yamaguchi S, et al. Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo 1998;44:13-6.
17. He L, Rong X, Jiang JM, Liu PQ, Li Y. Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine. Food Chem Toxicol 2008;46:1452-60.
18. Ning L, Chen CX, Jin RM, Wu YP, Zhang HG, Sun CL, et al. Effect of components of dang-gui-bu-xue decoction on hematopenia. Zhongguo Zhong Yao Za Zhi 2002;27:50-3.
19. Song ZH, Ji ZN, Lo CK, Dong TT, Zhao KJ, Li OT, et al. Chemical and biological assessment of a traditional chinese herbal decoction prepared from Radix Astragali and Radix Angelicae Sinensis: Orthogonal array design to optimize the extraction of chemical constituents. Planta Med 2004;70:1222-7.
20. Dong TT, Zhao KJ, Gao QT, Ji ZN, Zhu TT, Li J, et al. Chemical and biological assessment of a chinese herbal decoction containing Radix Astragali and Radix Angelicae Sinensis: Determination of drug ratio in having optimized properties. J Agric Food Chem 2006;54:2767-74.
21. Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 2003;10:465-76.
22. Hsieh CC, Lin WC, Lee MR, Hsu SL, Liu HS, Kao ST, et al. Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice. Immunopharmacol Immunotoxicol 2003;25:259-71.
23. Zhang YW, Xie D, Xia B, Zhen RT, Liu IM, Cheng JT. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats. Horm Metab Res 2006;38:82-8.
24. Liu IM, Tzeng TF, Liou SS. A Chinese herbal decoction, Dang Gui Bu Xue Tang, prepared from Radix Astragali and Radix Angelicae sinensis, ameliorates insulin resistance induced by a high-fructose diet in rats. Evid Based Complement Alternat Med 2011;2011:248231.
25. Chen L, Qi J, Chang YX, Zhu D, Yu B. Identification and determination of the major constituents in Traditional Chinese Medicinal formula Danggui-Shaoyao-San by HPLC-DAD-ESI-MS/MS. J Pharm Biomed Anal 2009;50:127-37.
26. Tsai HY, Lin YT, Tsai CH, Chen YF. Effects of paeoniflorin on the formalin-induced nociceptive behaviour in mice. J Ethnopharmacol 2001;75:267-71.
27. Huang WY, Sheu SJ. Separation and identification of the organic acids in Angelicae Radix and Ligustici Rhizoma by HPLC and CE. J Sep Sci 2006;29:2616-24.
28. Dong H, He L, Huang M, Dong Y. Anti-inflammatory components isolated from Atractylodes macrocephala Koidz. Nat Prod Res 2008;22:1418-27.
29. Huang YT, Huang DM, Chueh SC, Teng CM, Guh JH. Alisol B acetate, a triterpene from Alismatis rhizoma, induces Bax nuclear translocation and apoptosis in human hormone-resistant prostate cancer PC-3 cells. Cancer Lett 2006;231:270-8.
30. Kikuchi T, Uchiyama E, Ukiya M, Tabata K, Kimura Y, Suzuki T, et al. Cytotoxic and apoptosis-inducing activities of triterpene acids from Poria cocos. J Nat Prod 2011;74:137-44.
31. Kotani N, Oyama T, Sakai I, Hashimoto H, Muraoka M, Ogawa Y, et al. Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea-a double-blind study. Am J Chin Med 1997;25:205-12.
32. Jiang H, Shen Y, Wang XG. Current progress of Chinese medicinal treatment of endometriosis. Chin J Integr Med 2010;16:283-8.
33. Kano Y, Takaguchi S, Nohno T, Hiragami F, Kawamura K, Iwama MK, et al. Chinese medicine induces neurite outgrowth in PC12 mutant cells incapable of differentiation. Am J Chin Med 2002;30:287-95.
34. Hatip-Al-Khatib I, Egashira N, Mishima K, Iwasaki K, Iwasaki K, Kurauchi K, et al. Determination of the effectiveness of components of the herbal medicine Toki-Shakuyaku-San and fractions of Angelica acutiloba in improving the scopolamine-induced impairment of rat's spatial cognition in eight-armed radial maze test. J Pharmacol Sci 2004;96:33-41.
35. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: A role for the glomerular endothelium? Diabetologia 2008;51:714-25.
36. Liu IM, Tzeng TF, Liou SS, Chang CJ. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription. J Ethnopharmacol 2009;124:211-8.
37. Liu IM, Tzeng TF, Liou SS, Chang CJ. Beneficial effect of traditional chinese medicinal formula danggui-shaoyao-san on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats. Evid Based Complement Alternat Med 2012;2012:140103.
38. Falk RJ, Scheinman JI, Mauer SM, Michael AF. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983;32:34-9.
39. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003;284:243-52.
40. Miyazono K. TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 2000;11:15-22.
41. Cruzado JM, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, et al. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004;53:1119-27.
42. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 2001;158:1653-63.
43. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004;25:971-1010.
44. Li JH, Huang XR, Zhu HJ, Johnson R, Lan HY. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions. Kidney Int 2003;63:2010-9.
45. Tian YC, Fraser D, Attisano L, Phillips AO. TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 2003;285:130-42.
46. Monkawa T, Hiromura K, Wolf G, Shankland SJ. The hypertrophic effect of transforming growth factor-beta is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27. J Am Soc Nephrol 2002;13:1172-8.
47. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, et al. Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008;233:4-11.
48. Lv ZM, Wang Q, Wan Q, Lin JG, Hu MS, Liu YX, et al. The role of the p38 MAPK signaling pathway in high glucose-induced epithelial-mesenchymal transition of cultured human renal tubular epithelial cells. PLoS One 2011;6:e22806.
49. Okazaki T, Sakon S, Sasazuki T, Sakurai H, Doi T, Yagita H, et al. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem Biophys Res Commun 2003;300:807-12.
50. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003;14:S250-3.
51. Dominguez JH, Tang N, Xu W, Evan AP, Siakotos AN, Agarwal R, et al. Studies of renal injury III: Lipid-induced nephropathy in type II diabetes. Kidney Int 2000;57:92-104.
52. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon-(carboxymethyl) lysine, is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 1996;271:9982-6.
53. Janero DR, Burghardt B. Analysis of cardiac membrane phospholipid peroxidation kinetics as malondialdehyde: Nonspecificity of thiobarbituric acid-reactivity. Lipids 1988;23:452-8.
54. Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 2007;18:567-79.
55. Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, et al. Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 2003;14:1816-24.
56. Mima A, Matsubara T, Arai H, Abe H, Nagai K, Kanamori H, et al. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy. Lab Invest 2006;86:927-39.
57. Janiak P, Bidouard JP, Cadrouvele C, Poirier B, Gouraud L, Grataloup Y, et al. Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Eur J Pharmacol 2006;534:271-9.
58. Lee BC, Choi JB, Cho HJ, Kim YS. Rehmannia glutinosa ameliorates the progressive renal failure induced by 5 - 6 nephrectomy. J Ethnopharmacol 2009;122:131-5.
59. Hodge HC, Downs WL, Panner BS, Smith DW, Maynard EA. Oral toxicity and metabolism of diuron (N-(3,4-dichlorophenyl)-N', N'-dimethylurea) in rats and dogs. Food Cosmet Toxicol 1967;5:513-31.
60. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: A statement from the international committee of medical journal editors. N Z Med J 2004;117:U1054.